Product Information
CLINDAMYCIN HCL 150 MG CAPSULE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1072 per EA under NDC 59762332801. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
150 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762332801
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLINDAMYCIN HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA050162On Market Since
5/22/1970
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN HCL 150 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 18.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1072 per EA |
|---|---|
| All-time high | $0.1398 (Jun 16, 2021) |
| All-time low | $0.0760 (Nov 20, 2024) |
| 52-week high | $0.1097 |
| 52-week low | $0.0979 |
| Median price | $0.1081 |
| Average price | $0.1105 |
| Largest weekly change | +26.2% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the clindamycin hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CLINDAMYCIN HCL 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN HCL 150 MG CAPSULE, manufactured by Mylan Pharmaceuticals Inc., is $0.1072 per EA (NDC 59762332801), effective Jun 24, 2026.
How has the price of CLINDAMYCIN HCL 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN HCL 150 MG CAPSULE has risen 18.5%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN HCL 150 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CLINDAMYCIN HCL 150 MG CAPSULE has ranged from a low of $0.0760 (Nov 20, 2024) to a high of $0.1398 (Jun 16, 2021), with a median of $0.1081 per EA.
Are there cheaper alternatives to CLINDAMYCIN HCL 150 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CLINDAMYCIN HCL 150 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures CLINDAMYCIN HCL 150 MG CAPSULE?
CLINDAMYCIN HCL 150 MG CAPSULE (NDC 59762332801) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification